|
Date Submitted:
12/11/07
Hits: 4 Rating: ![]() ![]() ![]() ![]() 0/5 based on 0 votes
Clinical Trials Update: June 22, 2007
Description:
This is a phase II study for people with multiple sclerosis who have cognitive impairment. Volunteers 18-64 who have at least a 9th grade education and a diagnosis of MS (relapsing remitting or secondary progressive) may be eligible. Candidates will be ineligible if they have memory deficits caused by significant neurological/psychological disorders, major depressive disorder, or are taking certain medications, including tricyclic antidepressants, antipsychotics, Strattera, or CNS stimulants.
Read the Complete Article Similar content: Clinical Trials Update: June 25, 2007, in Multiple Sclerosis Clinical Trials Update: June 28, 2007, in Prostate Cancer Clinical Trials Update: Feb. 28, 2007, in Arthritis Clinical Trials Update: Jan. 19, 2007, in Leukemia Clinical Trials Update: Aug. 20, 2007, in Prostate Cancer |

